Who
Brittany Bradrick
Director
Company insider
Files Form 4 as: Director, Dermata Therapeutics; Director, Spectrum Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 12 Jan 2022
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 13 Jan 2025filed 14 Jan 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 4 Jan 2024filed 5 Jan 2024 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 31 Jul 2023filed 1 Aug 2023 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —86,301 | filing |
| 31 Jul 2023filed 1 Aug 2023 | Spectrum Pharmaceuticals | SEC FORM 4 Code D | —27,380 | filing |
| 6 Oct 2022filed 7 Oct 2022 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,810 at $0.00 | filing |
| 31 Aug 2022filed 2 Sep 2022 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —86,301 at $0.00 | filing |
| 31 Aug 2022filed 2 Sep 2022 | Spectrum Pharmaceuticals | SEC FORM 4 Code A | —27,380 at $0.00 | filing |
| 7 Jul 2022filed 8 Jul 2022 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —8,602 at $0.00 | filing |
| 7 Apr 2022filed 8 Apr 2022 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,031 at $0.00 | filing |
| 12 Jan 2022filed 14 Jan 2022 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.